Iradimed Corp
Research Iradimed Corp (IRMD) on Bullrun: valuation model: 10.8% overvalued, market cap USD 1.12B, P/E 49.0, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIRMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal10.8% overvalued
- Market capUSD 1.12B
- P/E49.0
- Dividend yield1.5%
- Financial periodQ2 2026
- RevenueUSD 20.47M
- Net incomeUSD 5.22M
- Free cash flowUSD 5.50M
- Gross margin74.1%
Valuation Snapshot
Bullrun's latest valuation model marks Iradimed Corp as 10.8% overvalued; latest market cap is USD 1.12B; P/E is 49.0; dividend yield is 1.5%.
Peer valuation comparison
Latest P/E is 49.05x versus a Healthcare sector median of 24.46x (100.5% above).
Latest dividend yield is 1.46% versus a Healthcare sector median of 2.11% (30.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 83.81M | USD 22.48M | USD 17.18M | 76.7% | 1.75 | USD 51.16M | USD 0 | USD 94.62M |
| FY2024 | USD 73.24M | USD 19.23M | USD 17.62M | 76.9% | 1.5 | USD 52.23M | USD 2.00K | USD 86.82M |
| FY2023 | USD 65.56M | USD 17.19M | USD 6.02M | 76.5% | 1.35 | USD 49.76M | USD 2.04M | USD 71.42M |
| FY2022 | USD 53.30M | USD 12.83M | USD 9.22M | 77.4% | 1.02 | USD 57.96M | USD 2.35M | USD 73.67M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.12B | 49.0 | 1.4% | 1.27 |
| 2025 | 2025-12-31 | USD 1.24B | 55.6 | 1.2% | 1.18 |
| 2024 | 2024-12-31 | USD 699.04M | 36.4 | 0.8% | 0.45 |
| 2023 | 2023-12-29 | USD 598.39M | 36.8 | 3.5% | 1.68 |
| 2022 | 2022-12-30 | USD 355.50M | 27.5 | 3.5% | 1 |
| 2021 | 2021-12-31 | USD 579.66M | 62.4 | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.27 USD, yield 1.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.18 USD |
| FY2024 | 0.45 USD |
| FY2023 | 1.68 USD |
| FY2022 | 1 USD |
About Iradimed Corp
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Iradimed Corp overvalued or undervalued?
Bullrun's valuation model currently marks Iradimed Corp as 10.8% overvalued.
What is Iradimed Corp's market cap?
Iradimed Corp's market capitalization is USD 1.12B.
What is Iradimed Corp's P/E ratio?
Iradimed Corp's price-to-earnings (P/E) ratio is 49.0.
Does Iradimed Corp pay a dividend?
Iradimed Corp has a dividend yield of 1.5%.
What does Iradimed Corp do?
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.